Pot Stock Surges 25.92% Wednesday: Should You Buy Tilray Inc (TLRY)?

Tilray Inc is a player in the cannabis industry that is higher by 25.92% Wednesday. The market has been down on Tilray Inc (TLRY) stock recently. TLRY gets a Bearish score from InvestorsObserver Stock Sentiment Indicator.

Tilray Inc has a Bearish sentiment reading. Find out what this means for you and get the rest of the rankings on TLRY!

See Full TLRY Report

What is Stock Sentiment?

Sentiment uses short term technical analysis to gauge whether a stock is desired by investors. As a technical indicator, it focuses on recent trends as opposed to the long term health of the underlying company. Updates for the company such as a earnings release can move the stock away from current trends. Recent trends are a good indicator of current market sentiments. In its most basic form, stocks that are trending up are desirable by investors while stocks currently falling must be unattractive. InvestorsObserver's Sentimental Indicator tracks both changes in price and volume to analyze the most recent trends. Typically an increase in volume indicates ongoing trends are getting stronger, while a decrease in volume usually signals an end to the current trend. Available options can also represent current sentiments for a given stock. Since investors are able to bet on future trends of stocks using options, we consider the ratio of calls to puts when analyzing market sentiments .

What's Happening With TLRY Stock Today?

Tilray Inc (TLRY) stock has risen 25.92% while the S&P 500 is down -0.09% as of 10:06 AM on Wednesday, Jul 28. TLRY is higher by $3.30 from the previous closing price of $12.73 on volume of 28,330,778 shares. Over the past year the S&P 500 is higher by 35.76% while TLRY is higher by 117.50%. TLRY lost -$2.70 per share in the over the last 12 months.

More About Tilray Inc

Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. In 2021, legacy Aphria acquired legacy Tilray in a reverse merger and renamed itself Tilray. The bulk of its sales are in Canada and in the international medical cannabis export market. U.S. exposure consists of CBD products through Manitoba Harvest and beer through SweetWater. Click Here to get the full Stock Report for Tilray Inc stock.